المؤلفون: Zhang Y; Department of Thoracic Surgery, Nanjing Drum Tower Hospital, Drum Tower Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, P.R. China., Zhu K; Department of Thoracic Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, Jiangsu, P.R. China., Wang X; Department of Thoracic Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, Jiangsu, P.R. China., Zhao Y; Department of Thoracic Surgery, Nanjing Drum Tower Hospital, Drum Tower Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, P.R. China., Shi J; Department of Thoracic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, P.R. China., Liu Z; Department of Thoracic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, P.R. China.

المصدر: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research [J Interferon Cytokine Res] 2024 Sep; Vol. 44 (9), pp. 399-407. Date of Electronic Publication: 2024 Mar 22.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 9507088 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7465 (Electronic) Linking ISSN: 10799907 NLM ISO Abbreviation: J Interferon Cytokine Res Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/immunology , Lung Neoplasms*/metabolism , Lung Neoplasms*/pathology , Interleukin-13*/metabolism , Interleukin-13*/immunology , Interleukin-4*/metabolism , Interleukin-4*/immunology, Humans ; Animals ; Signal Transduction/immunology ; Receptors, Interleukin-4/metabolism ; Receptors, Interleukin-4/immunology ; Receptors, Interleukin-13/metabolism ; Receptors, Interleukin-13/immunology ; Tumor Microenvironment/immunology

المؤلفون: McCann MR; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kosloski MP; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Xu C; Sanofi, Bridgewater, New Jersey, USA., Davis JD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kamal MA; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.

المصدر: Clinical and translational science [Clin Transl Sci] 2024 Aug; Vol. 17 (8), pp. e13899.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/pharmacology , Interleukin-4 Receptor alpha Subunit*/antagonists & inhibitors , Interleukin-4 Receptor alpha Subunit*/metabolism , Dermatitis, Atopic*/drug therapy , Dermatitis, Atopic*/immunology , Interleukin-13*/antagonists & inhibitors , Interleukin-13*/metabolism , Interleukin-13*/immunology , Translational Research, Biomedical*, Humans ; Interleukin-4/antagonists & inhibitors ; Interleukin-4/metabolism ; Asthma/drug therapy ; Asthma/immunology ; Eosinophilic Esophagitis/drug therapy ; Eosinophilic Esophagitis/immunology ; Signal Transduction/drug effects ; Nasal Polyps/drug therapy ; Nasal Polyps/immunology ; Prurigo/drug therapy ; Translational Science, Biomedical ; Sinusitis/drug therapy ; Sinusitis/immunology

المؤلفون: Zhang J; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China., Dong Y; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Yu S; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Hu K; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Zhang L; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Xiong M; Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, China., Liu M; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Sun X; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Li S; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Yuan Y; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Zhang C; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Zhu M; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Wei Y; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Zhu Y; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China., Yu Y; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China. yu.yiyi@zs-hospital.sh.cn.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China. yu.yiyi@zs-hospital.sh.cn., Zhang P; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China. zhang.pengfei@zs-hospital.sh.cn.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China. zhang.pengfei@zs-hospital.sh.cn., Liu T; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China. liutianshu1969@126.com.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China. liutianshu1969@126.com.

المصدر: Cell death & disease [Cell Death Dis] 2024 Jul 13; Vol. 15 (7), pp. 500. Date of Electronic Publication: 2024 Jul 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-4*/metabolism , Macrophages*/metabolism , Macrophages*/immunology , Receptors, IgG*/metabolism , Signal Transduction* , Immunotherapy*/methods , Up-Regulation* , Stomach Neoplasms*/pathology , Stomach Neoplasms*/metabolism , Stomach Neoplasms*/immunology , Stomach Neoplasms*/therapy, Humans ; Male ; Drug Resistance, Neoplasm/drug effects ; Female ; Receptors, Interleukin-4/metabolism ; Middle Aged ; Animals ; Aged

المؤلفون: Williams D; Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA., Hargrove-Wiley E; Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA., Bindeman W; Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA., Valent D; Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA., Miranda AX; Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA., Beckstead J; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA., Fingleton B; Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 24; Vol. 25 (9). Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Cell Proliferation* , Epigenesis, Genetic* , Receptors, Interleukin-4*/metabolism , Receptors, Interleukin-4*/genetics , Triple Negative Breast Neoplasms*/metabolism , Triple Negative Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/pathology, Animals ; Female ; Humans ; Acetylation ; Cell Line, Tumor ; Disease Progression ; Gene Expression Regulation, Neoplastic ; Glucose/metabolism ; Glucose Transporter Type 1/metabolism ; Glucose Transporter Type 1/genetics ; Interleukin-4/metabolism ; Interleukin-4/genetics ; Signal Transduction

المؤلفون: Ramos Solis N; Department of Pharmacology and Toxicology, Indiana University School of Medicine Indianapolis, Indianapolis, IN, USA.; Simon Comprehensive Cancer Center, Indiana University School of Medicine Indianapolis, Indianapolis, IN, USA., Cannon A; Department of Microbiology and Immunology, Indiana University School of Medicine Indianapolis, Indianapolis, IN, USA., Dilday T; Department of Pharmacology and Toxicology, Indiana University School of Medicine Indianapolis, Indianapolis, IN, USA.; Simon Comprehensive Cancer Center, Indiana University School of Medicine Indianapolis, Indianapolis, IN, USA., Abt M; Department of Pharmacology and Toxicology, Indiana University School of Medicine Indianapolis, Indianapolis, IN, USA., Oblak AL; Department of Radiology and Imaging Sciences, Indiana University School of Medicine Indianapolis, Indianapolis, IN, USA., Soloff AC; Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA., Kaplan MH; Department of Microbiology and Immunology, Indiana University School of Medicine Indianapolis, Indianapolis, IN, USA.; Simon Comprehensive Cancer Center, Indiana University School of Medicine Indianapolis, Indianapolis, IN, USA., Yeh ES; Department of Pharmacology and Toxicology, Indiana University School of Medicine Indianapolis, Indianapolis, IN, USA.; Simon Comprehensive Cancer Center, Indiana University School of Medicine Indianapolis, Indianapolis, IN, USA.

المصدر: Oncoimmunology [Oncoimmunology] 2024 Jun 05; Vol. 13 (1), pp. 2364382. Date of Electronic Publication: 2024 Jun 05 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/immunology , Triple Negative Breast Neoplasms*/metabolism , Tumor-Associated Macrophages*/immunology , Tumor-Associated Macrophages*/metabolism , Interleukin-4*/metabolism, Humans ; Female ; Animals ; Mice ; STAT3 Transcription Factor/metabolism ; STAT3 Transcription Factor/genetics ; Cell Line, Tumor ; Signal Transduction ; Gene Expression Regulation, Neoplastic ; Receptors, Interleukin-4/metabolism ; Receptors, Interleukin-4/genetics

المؤلفون: Li J; Department of Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China., Liu X; Research Center, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China., Jiang H; Department of Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China., Yang M; Department of Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

المصدر: Journal of biomedical materials research. Part B, Applied biomaterials [J Biomed Mater Res B Appl Biomater] 2024 Sep; Vol. 112 (9), pp. e35473.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101234238 Publication Model: Print Cited Medium: Internet ISSN: 1552-4981 (Electronic) Linking ISSN: 15524973 NLM ISO Abbreviation: J Biomed Mater Res B Appl Biomater Subsets: MEDLINE

مواضيع طبية MeSH: Gelatin*/chemistry , Gelatin*/pharmacology , Chondrogenesis*/drug effects , Interleukin-4*/metabolism , Interleukin-4*/pharmacology , Ear Cartilage* , Hydrogels*/chemistry , Hydrogels*/pharmacology , Chondrocytes*/metabolism , Chondrocytes*/cytology , Tissue Engineering*, Animals ; Rabbits ; Methacrylates/chemistry ; Methacrylates/pharmacology ; Cell Proliferation/drug effects

المؤلفون: Gottipati MK; Department of Biomedical Engineering, Rensselaer Polytechnic Institute, 110 8th Street, Troy, NY 12180, United States of America.; Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, NY 12180, United States of America.; Department of Neuroscience, The Ohio State University, 460 W. 12th Avenue, Columbus, OH 43210, United States of America.; Center for Brain and Spinal Cord Repair, The Ohio State University, 460 W. 12th Avenue, Columbus, OH 43210, United States of America., D'Amato AR; Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, 134 Hollister Drive, 283 Kimball Hall, Ithaca, NY 14853, United States of America., Saksena J; Department of Biomedical Engineering, Rensselaer Polytechnic Institute, 110 8th Street, Troy, NY 12180, United States of America.; Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, NY 12180, United States of America., Popovich PG; Department of Neuroscience, The Ohio State University, 460 W. 12th Avenue, Columbus, OH 43210, United States of America.; Center for Brain and Spinal Cord Repair, The Ohio State University, 460 W. 12th Avenue, Columbus, OH 43210, United States of America., Wang Y; Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, 134 Hollister Drive, 283 Kimball Hall, Ithaca, NY 14853, United States of America., Gilbert RJ; Department of Biomedical Engineering, Rensselaer Polytechnic Institute, 110 8th Street, Troy, NY 12180, United States of America.; Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, NY 12180, United States of America.

المصدر: Journal of neural engineering [J Neural Eng] 2024 Aug 14; Vol. 21 (4). Date of Electronic Publication: 2024 Aug 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Institute of Physics Pub Country of Publication: England NLM ID: 101217933 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-2552 (Electronic) Linking ISSN: 17412552 NLM ISO Abbreviation: J Neural Eng Subsets: MEDLINE

مواضيع طبية MeSH: Astrocytes*/drug effects , Astrocytes*/metabolism , Interleukin-4*/administration & dosage , Interleukin-4*/metabolism , Recovery of Function*/drug effects , Recovery of Function*/physiology , Spinal Cord Injuries*/drug therapy , Spinal Cord Injuries*/physiopathology , Spinal Cord Injuries*/metabolism, Animals ; Female ; Mice ; Cells, Cultured ; Delayed-Action Preparations/administration & dosage ; Macrophages/drug effects ; Macrophages/metabolism ; Mice, Inbred C57BL ; Phenotype

المؤلفون: Paton NI; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Infectious Diseases Translational Research Programme, National University of Singapore, Singapore, Singapore.; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom., Gurumurthy M; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lu Q; Singapore Clinical Research Institute, Singapore, Singapore, Singapore., Leek F; Clinical Imaging Research Centre, National University of Singapore, Singapore, Singapore., Kwan P; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Koh HWL; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Molton J; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Mortera L; Quezon Institute, Quezon City, Philippines., Naval S; Lung Centre of the Philippines, Quezon City, Philippines., Bakar ZA; Institute of Respiratory Medicine, Kuala Lumpur, Malaysia., Pang YK; University of Malaya Medical Centre, Kuala Lumpur, Malaysia., Lum L; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lim TK; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Cross GB; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lekurwale G; Singapore Clinical Research Institute, Singapore, Singapore, Singapore., Choi H; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Au V; Institute of Cellular and Molecular Biology, Singapore, Singapore., Connolly J; Institute of Cellular and Molecular Biology, Singapore, Singapore., Hibberd M; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Microbiology, National University of Singapore, Singapore, Singapore., Green JA; GSK, Greenford, United Kingdom.

مؤلفون مشاركون: Pascolizumab Tuberculosis Trial Team

المصدر: The Journal of infectious diseases [J Infect Dis] 2024 Sep 23; Vol. 230 (3), pp. 590-597.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Tuberculosis, Pulmonary*/drug therapy , Rifampin*/administration & dosage , Rifampin*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Interleukin-4*, Humans ; Double-Blind Method ; Adult ; Female ; Male ; Middle Aged ; Antitubercular Agents/administration & dosage ; Antitubercular Agents/therapeutic use ; Antitubercular Agents/adverse effects ; Treatment Outcome ; Young Adult ; Proof of Concept Study ; Drug Therapy, Combination ; Dose-Response Relationship, Drug ; Placebos/administration & dosage

المؤلفون: Biswas B; Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, West Bengal, India., Chattopadhyay S; Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, West Bengal, India., Hazra S; Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, West Bengal, India., Goswami R; Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, West Bengal, India.

المصدر: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2024 Sep 15; Vol. 213 (6), pp. 831-842.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE

مواضيع طبية MeSH: GATA3 Transcription Factor*/metabolism , GATA3 Transcription Factor*/genetics , Receptors, Calcitriol*/metabolism , Receptors, Calcitriol*/genetics , Calcitriol*/pharmacology , Interleukin-4*/metabolism , Interleukin-4*/immunology , Interleukin-13*/metabolism , Interleukin-13*/immunology , Th2 Cells*/immunology, Animals ; Mice ; Humans ; Transcription Factors/metabolism ; Transcription Factors/genetics ; DNA-Binding Proteins/metabolism ; DNA-Binding Proteins/genetics

المؤلفون: Mizuno N; Department of Pharmacology, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Kanazawa 1757, Tobetsu, Ishikari, 061-0293, Japan. Electronic address: n-mizuno@hoku-iryo-u.ac.jp., Shiga S; Department of Pharmacology, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Kanazawa 1757, Tobetsu, Ishikari, 061-0293, Japan., Tanaka Y; Department of Pharmacology, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Kanazawa 1757, Tobetsu, Ishikari, 061-0293, Japan., Kimura T; Department of Pharmacology, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Kanazawa 1757, Tobetsu, Ishikari, 061-0293, Japan., Yanagawa Y; Department of Pharmacology, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Kanazawa 1757, Tobetsu, Ishikari, 061-0293, Japan.

المصدر: European journal of pharmacology [Eur J Pharmacol] 2024 Sep 15; Vol. 979, pp. 176852. Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Arginase*/metabolism , Arginase*/antagonists & inhibitors , STAT6 Transcription Factor*/metabolism , p38 Mitogen-Activated Protein Kinases*/metabolism , p38 Mitogen-Activated Protein Kinases*/antagonists & inhibitors , Cyclin-Dependent Kinases*/antagonists & inhibitors , Cyclin-Dependent Kinases*/metabolism , Interleukin-4*/metabolism , Cyclin-Dependent Kinase 8*/antagonists & inhibitors , Cyclin-Dependent Kinase 8*/metabolism, Animals ; Mice ; RAW 264.7 Cells ; Protein Kinase Inhibitors/pharmacology ; Macrophages/drug effects ; Macrophages/metabolism ; Phosphorylation/drug effects ; Macrophages, Peritoneal/drug effects ; Macrophages, Peritoneal/metabolism ; Enzyme Activation/drug effects ; Flavonoids ; Piperidines ; Cyclin-Dependent Kinase 9